Transcatheter aortic valve implantation (TAVI) is a new treatment of patients with aortic stenosis who are at high risk for conventional open heart surgery or considered inoperable. Imaging is recommended for these patients. In this context, we define the role of the echocardiographic specialist within the TAVI team.
INTRODUCTION
The prevalence of aortic stenosis increases with age, affecting approximately 3% of the population over the age of 75. The surgical replacement of the aortic valve can offer the patients with symptom relief and increases their survival rate. But, nearly 30% of patients with symptomatic aortic stenosis cannot have a surgical correction due to substantial comorbidities. TAVR has emerged as an alternative treatment with two types of prostheses currently available for clinical use and supported by the largest studies, the Medtronic CoreValve (Medtronic, Minneapolis, MN, USA) and the Edwards SAPIEN/SAPIEN XT valves (Edwards Lifesciences, Irvine, CA, USA). However, there are several transcatheter AV prostheses under development or clinical evaluation.
Imaging, especially echocardiography, is recommended for patient selection, choice of procedural access, prosthetic choice and sizing, procedural guidance, and detection of early and late complications. Initially, complications with TAVI were frequent and many of them were related to the large sheath sizes used for vascular access.
Furthermore, a significant improvement was noted in the delivery system, the prosthesis and the procedure leading to lower complication rate.
ROLE OF ECHOCARDIOGRAPHY IN SELECTION
Echocardiography is used to assess aortic stenosis severity, annular dimension and detailed anatomic characteristics of the aortic valve. These data are crucial in the pre procedural evaluation of candidates for TAVI.
Severity/Morphology of Aortic Stenosis
Baseline AV gradients are best assessed with TTE and severity of aortic stenosis is assessed according to current guidelines [1] . A severe aortic stenosis is defined as a maximum systolic continuous wave Doppler velocity of more than 4m/s, a mean valve gradient of more than 40mmHg and a calculated aortic valve area of less than 1 cm².
The unicuspid and bicuspid valves have been relatively contraindicated to TAVI as there is a risk of incomplete prosthetic deployment within the abnormal valve geometry [2] .
Extensive or asymmetric calcification of the edge of the leaflets and the commissures may result in unfavourable deployment of the valve and complications like coronary occlusion and paraprosthetic regurgitation. Twodimensional transoesophageal echocardiography (TEE) is the method of choice in evaluating bicuspid valve and asymmetry of cusps, and extent and location of calcification [3] .
Some centres have reported successful TAVI procedures in patients with bicuspid AV but,
where there is an eccentric orifice and eccentric calcification, the risk of malposition and valve embolization is high [4] .
Annular Dimension
Annular dimension is a key measurement. It determines eligibility for TAVI and guides the selection of valve type and size. It is measured in systole, in a parasternal long axis view, at the mid-oesophagus level with 120̊ rotation zoomed on the left ventricular outflow tract. The measurement is taken at the point of insertion of the aortic valve cusps, from tissue blood interface to blood tissue interface-trailing edge to leading edge, regardless of the degree of calcification of the aortic cusps.
However, 2D TEE may underestimate or overestimate the true anteroposterior annulus dimension, due to off-axis imaging. The maximum annulus dimension may also be underestimate since the annulus is often elliptical rather than circular.
In this case, 3D TEE can be very useful in accurately sizing the annulus because aligning the short axis view of the aortic valve to present the true annulus, allows the assessment of its circularity and the measurement of the maximum diameters.
3D TEE dimensions showed a high correlation with those obtained by multidetector computed tomography while TTE and 2D TEE aortic valve annulus dimensions are consistently smaller [5] [6] [7] .
An undersized valve can lead to paravalvular regurgitation. Calculation of a cover index has been proposed to be a predictor of paravalvular aortic regurgitation. This index is defined as a 100 x (prosthesis diameter -transoesophageal echocardiography annulus diameter)/prosthesis diameter It has been reported that paravalvular aortic regurgitation did not occur when the cover index was superior to 8% [8] .
Other Measurements
In order to minimize the risk of coronary occlusion, it is essential to know the distance from the aortic annulus to the ostia of the coronary arteries and to compare this to the length of the cusps measured in a long axis view.
While AV annulus-right coronary ostial height can be measured in a 2DTEE modified midoesophageal long-axis view, aortic valve annulus-left coronary ostial height can only be measured using 3D techniques (at the coronal plane) or multidetector computed tomography.
The severity of AR should be determined using 2D TTE and TEE techniques according to current guidelines [1] .
It is important to define the baseline AR severity as it may be significantly increased during procedure.
A significant LVOT obstruction due to basal septal hypertrophy should be excluded, as this may lead to valve displacement during or after implantation.
The baseline study must evaluate mitral valve anatomy and severity of mitral regurgitation, LV size and systolic function, regional wall motion abnormalities, right heart ventricle and pericardial effusion. This enables the echocardiographer direct comparison when complications occur.
INTRAPROCEDURAL ECHOCARDIOGRAPHY
Both 2D and 3D TEE along with fluoroscopy are used for intra-procedural guidance, in the three main steps: guidewire and delivery system positioning, balloon aortic valvuloplasty and valve positioning and deployment.
However, the need for patient sedation in order to tolerate the TEE probe is a disadvantage of TEE (Table 1) . So, some institutions performed this procedure under fluoroscopy only. 3D imaging has advantages in procedural guidance. It's used before, during and after the deployment of the bioprosthetic valve to better assess the aortic valve diameter and catheter orientation. 3D TEE is superior to 2DTTE and can precise multiplanar dimension and more anatomic detail of the aortic root and valve.
• Guidewire/delivery system positioning
The passage of the guidewire can be monitored by 2D or 3D TEE. The guidewire can interfering with the mitral apparatus resulting in severe acute mitral regurgitation and marked hypotension.
So, the echocardiographer attempt to help the interventionalist to select another catheter position away from the mitral apparatus.
• Balloon aortic valvuloplasty:
TEE, particularly 3DTEE, is used to guide the balloon positioning and is useful in cases where the valve is less calcified and, thus, less well identified on fluoroscopy, and in valve-in-valve procedures.
Following balloon aortic valvuloplasty, native cusp mobility and AR severity should be reassessed.
• Valve positioning and deployment:
The proximal and distal margins of the balloon-mounted transcatheter valve are well seen with 3DTEE.
Optimal deployment of the bioprosthesis is generally considered to be with 60% of the prosthesis above the annulus and 40% below the aortic annulus (Figure1). A too high position can leads to prosthesis migration into the aorta, coronary ostial occlusion with myocardial infarction and paravalvular regurgitation.
If the valve is deployed misaligned to the center axis of aortic annulus, it can lead to angulation of the bioprosthesis with a significant paravalvular aortic regurgitation. In this condition, wire manipulation or the adjustment of the catheter can improve the coaxial alignment before deployment.
Valve malposition or embolization rates of 1.2-4% are reported [9] .
The optimal position of the Edwards-Sapien valve is with the ventricular side of the prosthesis positioned 2-4mm below the annulus in the left ventricular outflow tract. Since the CoreValve has a different structure, the ventricular edge of the prosthesis should be placed 5-10mm below the aortic valve annular plane [10] .
Some patients have an oval, calcified or rigid aortic annulus, contrasting with a circular bioprosthesis and exposing these patients to a usually small paravalvular aortic regurgitation.
After deployment, 2D TEE and 3D TEE can precise the location and severity of a paravalular or transvalvular leak.
It can be paravalvular (Figure 2 ), transvalvular or a combinaison of both. Conventional parameters for AR severity are helpful in the evaluation of transvalvular regurgitation but less so in paravalvular regurgitation. Assessment of paravalvular regurgitation can be difficult as there is often more than one site with eccentric jets. In the PARTNER trial echo sub study, paravalvular aortic regurgitation was graded according to the Valve Academic Research Consortium Criteria (Table 2 ) [11] . In this consensus, the circumferential extent of the regurgitation in the short axis view at the level of the vena contracta, was introduced in addition to traditional assessment criteria. Paravalvular aortic regurgitation is graded severe when the circumferential extent is greater than 20%, the proportion of the jet width occupying the left ventricular outflow tract is greater than 65%, a dense jet on continuous wave Doppler and a pressure half time is less than 200ms.
It must be noted, however, that there is very limited data on the application and validation of quantitative parameters such as the regurgitant orifice area or volume or the width of the regurgitant jet in the case of transcatheter aortic valve.
Mild paravalvular aortic regurgitation was present in approximately 40% of TAVI patients at 2 year follow-up, but moderate to severe regurgitation was noted in 7% of TAVI patients.
The paravalvular regurgitation rate has changed significantly due to technological improvements.
It was seen that the agreement between the different echocardiographic parameters in assessing paravalvular leak severity is poor, and a multimodality, multiparametric, integrative approach is essential to accurately assess the severity of paravalvular regurgitation and the underlying mechanism [12] .
The mechanism of aortic regurgitation must be well defined: it may be a consequence of incorrect position, incomplete expansion of the prosthesis, restricted cusp motion or inappropriate prosthetic size.
Depending on the mechanism, significant regurgitation may be an indication for balloon dilatation or implantation of a second valve.
If the paravalvular aortic regurgitation is significant, we can used a post-deployment balloon dilatation to improve apposition of the bioprosthesis to the aortic annulus Paravalvular regurgitation is an important predictor of 30-day and 1-year mortality in TAVI procedures [13, 14] . TEE can detect other main complications such cardiac tamponade, aortic root rupture or ventricular septal rupture, acute mitral regurgitation, coronary obstruction and acute ventricular dysfunction and aortic dissection. Endocarditis and apical pseudoaneurysm (in transapical approach) can be observed as late complications.
•
Coronary obstruction:
When the prosthesis is placed too aortic (high), a coronary obstruction can occurred. This complication can be identified by direct anatomic visualization, high velocity Doppler flow in the coronary artery or by ventricular dysfunction shortly after deployment.
• Aortic annulus rupture:
It's an extremely rare complication with an incidence of 0.5%. The presence of small sinuses relative to annulus size and a narrow sinotubular junction may increase the risk of aortic rupture.
• Aortic dissection:
Aortic dissection can occur at different stages of the procedure, despite the smaller recently developed systems. This complication must be searched especially in the setting of hemodynamic instability.
This complication can leads to late deaths when it was not recognized during procedure [15] .
• Stroke:
After TAVI, the incidence of Stroke has been reported to be between 1.7 and 8.4% [16] .
CONCLUSION
Echocardiography provides an excellent real-time 2D and 3D imaging of the heart, making it the imaging modality of choice immediately before, during, and after TAVI.
A multimodality approach can be used to better select patients and prevent some complications.
